Evidence map›Paper›PMID 28208719›Full record

ArticleInternational journal of molecular sciences2017

Micro-Computed Tomography Detection of Gold Nanoparticle-Labelled Mesenchymal Stem Cells in the Rat Subretinal Layer.

Pooi Ling Mok, Sue Ngein Leow, Avin Ee-Hwan Koh, Hairul Harun Mohd Nizam, Suet Lee Shirley Ding, Chi Luu, Raduan Ruhaslizan, Hon Seng Wong, Wan Haslina Wan Abdul Halim, Min Hwei Ng and 7 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Recent advances in non-invasiveBiomaterials science · 2025
    Review
  3. Article
  4. Molecular and cellular imaging of the eye.Biomedical optics express · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Nanotechnology in regenerative ophthalmology.Advanced drug delivery reviews · 2019
    Review
  11. Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Pooi Ling MokDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. rachelmok2005@gmail.com.
Sue Ngein LeowDepartment of Ophthalmology, Hospital Sultanah Aminah, 80100 Johor Bahru, Johor, Malaysia. sue_ngein@yahoo.com.
Avin Ee-Hwan KohDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. avin.keh@gmail.com.
Hairul Harun Mohd NizamDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. hairulnizam@ppukm.ukm.edu.my.
Suet Lee Shirley DingDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. suetlee.ding@gmail.com.
Chi LuuCentre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne 3002, Australia. cluu@unimelb.edu.au.
Raduan RuhaslizanDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. ruhaslizan89@gmail.com.
Hon Seng WongDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. whs1975@gmail.com.
Wan Haslina Wan Abdul HalimDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. afifiyad@yahoo.co.uk.
Min Hwei NgTissue Engineering Centre, Universiti Kebangsaan Malaysia Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. angelaster3@gmail.com.
Ruszymah Binti Hj IdrusDepartment of Physiology, Universiti Kebangsaan Malaysia Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. ruszyidrus@gmail.com.
Shiplu Roy ChowdhuryTissue Engineering Centre, Universiti Kebangsaan Malaysia Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. shipluchy_56@yahoo.com.
Catherine Mae-Lynn BastionDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. maelynnbdr@gmail.com.
Suresh Kumar SubbiahGenetics and Regenerative Medicine Research Center, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. sureshkudsc@gmail.com.
Akon HiguchiDepartment of Chemical and Materials Engineering, National Central University, Jhong-li, Taoyuan 32001, Taiwan. akon.higuchi@gmail.com.
Abdullah A AlarfajDepartment of Botany and Microbiology, King Saud University, Riyadh 11451, Saudi Arabia. aalarfajj@ksu.edu.sa.
Kong Yong ThenDepartment of Ophthalmology, Faculty of Medicine, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia. kythen@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells are widely used in many pre-clinical and clinical settings. Despite advances in molecular technology; the migration and homing activities of these cells in in vivo systems are not well understood. Labelling mesenchymal stem cells with gold nanoparticles has no cytotoxic effect and may offer suitable indications for stem cell tracking. Here, we report a simple protocol to label mesenchymal stem cells using 80 nm gold nanoparticles. Once the cells and particles were incubated together for 24 h, the labelled products were injected into the rat subretinal layer. Micro-computed tomography was then conducted on the 15th and 30th day post-injection to track the movement of these cells, as visualized by an area of hyperdensity from the coronal section images of the rat head. In addition, we confirmed the cellular uptake of the gold nanoparticles by the mesenchymal stem cells using transmission electron microscopy. As opposed to other methods, the current protocol provides a simple, less labour-intensive and more efficient labelling mechanism for real-time cell tracking. Finally, we discuss the potential manipulations of gold nanoparticles in stem cells for cell replacement and cancer therapy in ocular disorders or diseases.

Indexed as

GoldMetal NanoparticlesX-Ray MicrotomographyAnimalsBiomarkersCell TrackingEyeImmunophenotypingMesenchymal Stem CellsPhenotypeRatsBiomarkersGoldgold nanoparticlesmesenchymal stem cellsmicro-computed tomographyrat subretinal layerstem cell trackingtransmission electron microscopy

Identifiers

PMID28208719
PMCPMC5343880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.